US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

81.17

+0.57000.71%

Volume:122.02K

Turnover:9.87M

Market Cap:3.52B

PE:- -

High:81.17

Open:80.53

Low:80.42

Close:80.60

52wk High:85.46

52wk Low:67.77

Shares:43.35M

Float Shares:43.35M

Volume Ratio:0.35

T/O Rate:0.28%

Dividend:1.02

Dividend Rate:1.25%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Former Eli Lilly Exec Sells Wyoming Estate for Close to $39.5 Million

Why Medtronic's $4 Billion MiniMed Exchange Offer is Losing Its Allure

Eli Lilly announces FDA approves additional indication for Jaypirca

Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca

Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll

THOMSON REUTERS

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live

AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors

Correction: Top Midday Decliners

MT Newswires Live

Abogen announces licensing, option agreement with Novartis

Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study

Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study

J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112

THOMSON REUTERS

Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~

THOMSON REUTERS

J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112

THOMSON REUTERS

J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals

THOMSON REUTERS

Major Drugmakers Turn to China for Licensing Deals

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/FHLC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FHLC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FHLC\",,,,,undefined,":{"symbol":"FHLC","market":"US","secType":"STK","nameCN":"Fidelity MSCI Health Care Index ETF","latestPrice":81.17,"timestamp":1791224939339,"preClose":80.6,"halted":0,"volume":122016,"delay":0,"changeRate":0.007071960297766842,"floatShares":43350000,"shares":43350000,"eps":0,"marketStatus":"Trading","change":0.57,"latestTime":"10-05 14:29:27 EDT","open":80.53,"high":81.17,"low":80.42,"amount":9866888.508480001,"amplitude":0.009305,"askPrice":81.18,"askSize":400,"bidPrice":81.16,"bidSize":400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791230400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":80.6,"sharesOutstanding":39450000,"nav":80.567556,"aum":3569142730.8,"dividendRate":0.012512,"bidAskSpread":0.0004,"preHourTrading":{"tag":"盘前","latestPrice":80.6,"preClose":80.6,"latestTime":"08:12 EDT","volume":23,"amount":1838.6002199999998,"timestamp":1791202360472,"change":0,"changeRate":0,"amplitude":0.009926},"postHourTrading":{"tag":"盘后","latestPrice":80.6,"preClose":80.6,"latestTime":"19:30 EDT","volume":25,"amount":2016.1428,"timestamp":1790983804989,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.350673,"impliedVol":0.1582,"impliedVolPercentile":0.8805},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FHLC\",,,,,undefined,":{"symbol":"FHLC","floatShares":43350000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.350673,"shares":43350000,"dividePrice":1.0156,"high":81.17,"amplitude":0.009305,"preClose":80.6,"low":80.42,"week52Low":67.772,"pbRate":"--","week52High":85.4649,"institutionHeld":0,"latestPrice":81.17,"eps":0,"divideRate":0.012512,"volume":122016,"delay":0,"ttmEps":0,"open":80.53,"prevYearClose":74.28,"prevWeekClose":80.6,"prevMonthClose":81.7,"prevQuarterClose":81.7,"fiveDayClose":82.92,"twentyDayClose":83.14,"sixtyDayClose":78.405},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FHLC\",params:#limit:5,,,undefined,":[{"date":"2026-09-18","symbol":"FHLC","amount":0.254,"announcedDate":"2026-09-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-18","defaultRemindTime":1789738200000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-22","payableDate":"2026-09-18","currency":"USD","dateTimestamp":1789704000000,"payDate":"2026-09-22"},{"date":"2026-06-18","symbol":"FHLC","amount":0.263,"announcedDate":"2026-06-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-23"},{"date":"2026-03-20","symbol":"FHLC","amount":0.229,"announcedDate":"2026-03-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-20","defaultRemindTime":1774013400000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-24","payableDate":"2026-03-20","currency":"USD","dateTimestamp":1773979200000,"payDate":"2026-03-24"},{"date":"2025-12-19","symbol":"FHLC","amount":0.272,"announcedDate":"2025-12-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-19","defaultRemindTime":1766154600000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-19","currency":"USD","dateTimestamp":1766120400000,"payDate":"2025-12-23"},{"date":"2025-09-19","symbol":"FHLC","amount":0.256,"announcedDate":"2025-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-19","defaultRemindTime":1758288600000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-19","currency":"USD","dateTimestamp":1758254400000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FHLC\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-22","value":0.117,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-23","value":0.125,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-22","value":0.137,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-20","value":0.132,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.134,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FHLC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FHLC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672574696","title":"Former Eli Lilly Exec Sells Wyoming Estate for Close to $39.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2672574696","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672574696?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:30","pubTimestamp":1790969400,"startTime":"0","endTime":"0","summary":"A former executive at Eli Lilly-maker of popular weight-loss drug Zepbound-has sold a roughly 117-acre estate in the Jackson Hole, Wyo., area for close to its asking price of $39.5 million in one of t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0385154629.USD","IE00BK4W5M84.HKD","IE00B7KXQ091.USD","LU2089284900.SGD","LU2491050154.USD","LU2461242641.AUD","AGNG","IE0004445015.USD","IE00B1BXHZ80.USD","LU0198837287.USD","LU2237438978.USD","LU2264538146.SGD","LU0079474960.USD","LU1988902786.USD","LU1548497426.USD","BK4516","IE0005OL40V9.USD","LU0823416689.USD","LU1093756168.USD","SGXZ31699556.SGD","LU1974910355.USD","LU0672654240.SGD","IE00BJLML261.HKD","LU1145028129.USD","LU2237443895.HKD","LU2213496289.HKD","LU0640476718.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","LU1979441026.SGD","LU2168564149.EUR","SG9999013999.USD","SG9999001176.SGD","LU0096364046.USD","IE00B775H168.HKD","IE0004445239.USD","LU0256863902.USD","LU1127390331.HKD","LU1814569148.SGD","LU1720051108.HKD","LU1868836591.USD","IE00BWXC8680.SGD","LU0109394709.USD","LU2023251221.USD","LU2271345857.HKD","PJP","LU2491050071.SGD","SGXZ57979304.SGD","ELIS","LU1720051017.SGD","ELIL","LU0266013472.USD","LU0787776722.HKD","SG9999014898.SGD","LU2168564065.EUR","LU0106261372.USD","LU2106854487.HKD","FHLC","LU0345770993.USD","LU1868836914.USD","LU1267930730.SGD","CANC","IE0001KFT4U8.USD","GB00BDT5M118.USD","LU0471298777.SGD","LU1323610961.USD","IE00B4R5TH58.HKD","WDNA","LU1232071149.USD","LU0158827948.USD","TRUH","THNR","LU0320765992.SGD","MEDI","IE00BFTCPJ56.SGD","LU2357305700.SGD","LU2750360997.AUD","SGXZ51526630.SGD","LU2552382132.HKD","LLYZ","LU2168564495.EUR","LU2237443382.USD","LU2462591350.SGD","LU0432979614.USD","VHT","IE00BFSS7M15.SGD","IE00B1XK9C88.USD","IE00BJJMRX11.SGD","LU1069344957.HKD","LU1868837300.USD","SG9999017495.SGD","IHE","LU2236285917.USD","LU1057294990.SGD","LU0094547139.USD","LU0345770308.USD","LU0174119429.USD","LU0354030438.USD","SG9999001176.USD","LU2237443978.SGD","LU0122379950.USD","LU2063271972.USD","SG9999015986.USD","LU1804176565.USD","LU0689472784.USD","LU2087625088.SGD","BK4581","LU1366192091.USD","LU2168564222.USD","LU2237443465.HKD","BK4588","LLII","LU0823434740.USD","SG9999018857.SGD","SG9999014914.USD","LU0316494557.USD","LU1023059063.AUD","IE0009355771.USD","JDOC","LU2471134952.CNY","IE00B2B36J28.USD","LU0889565916.HKD","LU2111349929.HKD","LU2468319806.SGD","LLYX","LU2602419157.SGD","IE00BKPKM429.USD","LU0061475181.USD","LU0203201768.USD","LU0820561909.HKD","LU0456855351.SGD","LU1551013425.SGD","LU2023250504.SGD","LU2265009873.SGD","LU0238689110.USD","LU0471298694.HKD","TMED","LU2750360641.GBP","LU2746668461.USD","LU1291159041.SGD","LU0820562030.AUD","LU2361044865.SGD","SGXZ99366536.SGD","LU1983299246.USD","LU0320765059.SGD","LU2237443549.SGD","LU0097036916.USD","LU1280957306.USD","LU0289739699.SGD","HRTS","LU0006306889.USD","IXJ","LU2089984988.USD","LLY","SG9999018865.SGD","ILDR","LU2237443622.USD","IE00BJT1NW94.SGD","LU0354030511.USD","LU2462157665.USD","IE00BJJMRY28.SGD","LU1035775433.USD","LU2361045086.USD","SG9999014906.USD","LU0708995401.HKD","LU0943347566.SGD","SG9999015978.USD","LU0417517546.SGD","LU0882574055.USD","LU0882574139.USD","LU1868836757.USD","XLV","LU0353189680.USD","LU2456880835.USD","LU1551013342.USD","LU2211815571.USD","GDOC","LU1623119135.USD","LU2028103732.USD","IE00BN29S564.USD","LU2112291526.USD","LU1629891620.HKD","LU0323591593.USD","LU1093756325.SGD","IE00B4JS1V06.HKD","LU2552382215.SGD","LU1868837136.USD","LU0683600562.USD","LU2089283258.USD","LU0256863811.USD","LU2552382058.USD","OZEM","BK4585","RXL","LU0786609619.USD","LU0109391861.USD","LU0353189763.USD","LU2324357040.USD","LU2168563687.JPY","FTXH","LU2491049909.HKD","LU0203202063.USD","LU2360106947.USD","IYH","LU0210536198.USD","LU0133085943.USD","LU0225283273.USD","LU0964807845.USD","IE0002141913.USD","LU2471134796.USD","LU0466842654.USD","MEDX","IE00BFSS8Q28.SGD","LU0058720904.USD","LU2023250330.USD","LU0823434583.USD","LU1691799644.USD","LU0820561818.USD","LU2756315318.SGD","BK4533","LU2417539215.USD","LU1061106388.HKD","CURE","LU2896262040.SGD","BK4007","LU2108987350.USD","IE00BKDWB100.SGD","LU2361044949.HKD","LU2471134523.USD","LU2471134879.HKD","PPH","SGXZ81514606.USD","BK4599","LU2746668974.SGD","SG9999015945.SGD","SG9999014880.SGD","LU0158827781.USD","LU1712237335.SGD","LU1064131342.USD","LU1917777945.USD","IE00BK4W5L77.USD","SG9999015952.SGD","LU1989771016.USD","LU2756315664.SGD","LU0114720955.EUR","MHIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672469877","title":"Why Medtronic's $4 Billion MiniMed Exchange Offer is Losing Its Allure","url":"https://stock-news.laohu8.com/highlight/detail?id=2672469877","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672469877?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:27","pubTimestamp":1790969220,"startTime":"0","endTime":"0","summary":"Medtronic's $4 billion exchange offer for its shares of MiniMed Group is a lot less attractive now that MiniMed's stock has dropped since the offer was unveiled a couple of weeks ago.That could reduce","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","IE00BZ1G4Q59.USD","MMED","LU1116320901.HKD","MEDX","IE00B42XCP33.USD","FTXH","IE00BLSP4239.USD","KVUE","IE00BJT1NW94.SGD","IE00BDGV0183.EUR","TRUH","IHE","VHT","LU0098860793.USD","LU2089984988.USD","IE00B1BXHZ80.USD","LU0210536198.USD","GDOC","MDT","SG9999002232.USD","LU2111349929.HKD","FHLC","LU1043141396.HKD","JNJ","BMED","LU1989764748.USD","XLV","IXJ","IE000M9KFDE8.USD","LU0354030511.USD","LU0976567544.SGD","LU1074936037.SGD","IE00B2B36J28.USD","GLAM","JDOC","LU1145028129.USD","EKG","IYH","LU0234572021.USD","PJP","DXCM","SG9999002224.SGD","LU2896262040.SGD","LU0029864427.USD","LU2129689431.USD","LU1244550221.USD","LU2505996509.AUD","RXL","RSPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672746160","title":"Eli Lilly announces FDA approves additional indication for Jaypirca","url":"https://stock-news.laohu8.com/highlight/detail?id=2672746160","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672746160?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:10","pubTimestamp":1790968214,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) and Company announced that the U.S. Food and Drug Administration FDA has approved an additional indication for Jaypirca, a non-cova...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-announces-fda-approves-additional-indication-for-jaypirca-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-announces-fda-approves-additional-indication-for-jaypirca-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMED","IE0004445239.USD","IE0005OL40V9.USD","SG9999014880.SGD","LU0786609619.USD","ELIL","LU1868836591.USD","ILDR","LU0058720904.USD","LU0353189680.USD","LU0787776722.HKD","LU1280957306.USD","LU1366192091.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU2746668974.SGD","LU0466842654.USD","SGXZ31699556.SGD","LU2168564149.EUR","BK4581","LU0889565916.HKD","GDOC","LU2028103732.USD","TRUH","LU1804176565.USD","LU2237438978.USD","LU0203202063.USD","LU0174119429.USD","LU0823416689.USD","LU0289739699.SGD","IE00B775H168.HKD","LU2236285917.USD","LU2361045086.USD","IE00BJJMRY28.SGD","LU2491050071.SGD","SG9999014906.USD","BK4533","SGXZ51526630.SGD","LU1057294990.SGD","LU0882574055.USD","LU2417539215.USD","LU0471298694.HKD","LU2108987350.USD","LU2756315318.SGD","LU2089283258.USD","LU2361044949.HKD","LU2471134952.CNY","LU0689472784.USD","IE00BWXC8680.SGD","BK4516","SG9999017495.SGD","BK4534","LU2168564065.EUR","SG9999015978.USD","SGXZ99366536.SGD","LU0943347566.SGD","LU2023250504.SGD","LU1623119135.USD","SG9999001176.SGD","LU1127390331.HKD","LU1232071149.USD","LU0708995401.HKD","LU2552382215.SGD","LU1988902786.USD","LU2265009873.SGD","LU2361044865.SGD","LU2112291526.USD","LU0109394709.USD","LU0354030511.USD","LU1267930730.SGD","LU0061475181.USD","MEDX","LU0096364046.USD","LU2756315664.SGD","IE00BJJMRX11.SGD","LU0203201768.USD","IE00BJLML261.HKD","LU2746668461.USD","LU1989771016.USD","LU1548497426.USD","LU0225283273.USD","IE00B7KXQ091.USD","LU2471134523.USD","LU0079474960.USD","LU1720051017.SGD","LU2461242641.AUD","IXJ","IE0009355771.USD","LU0158827948.USD","VHT","LU0256863902.USD","FHLC","FTXH","LU0672654240.SGD","LU0097036916.USD","IE00BJT1NW94.SGD","LU2471134879.HKD","LU2360106947.USD","BK4007","LU0114720955.EUR","GB00BDT5M118.USD","LU0133085943.USD","LU0345770308.USD","LU2168564222.USD","LU2462157665.USD","LU2750360997.AUD","LU0106261372.USD","LU0266013472.USD","LU2111349929.HKD","SG9999013999.USD","LU1023059063.AUD","SG9999018865.SGD","LU2552382132.HKD","LU0234572021.USD","LU2462591350.SGD","IE00BFTCPJ56.SGD","OZEM","LU2168563687.JPY","LU2237443382.USD","SG9999014898.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU0964807845.USD","LU1093756325.SGD","LU2264538146.SGD","LU0210536198.USD","PPH","LU2023250330.USD","IHE","LU2237443465.HKD","LU1061106388.HKD","LU0823434740.USD","LU1720051108.HKD","JDOC","AGNG","IE0001KFT4U8.USD","LU2468319806.SGD","LU0683600562.USD","LU1069344957.HKD","IE00B4JS1V06.HKD","LU2089984988.USD","LU0256863811.USD","LU1868837300.USD","LU2168564495.EUR","IE00BK4W5L77.USD","SG9999014914.USD","LU0820561909.HKD","LU2491049909.HKD","LU1868836914.USD","LU2211815571.USD","LU2213496289.HKD","LU1323610961.USD","SG9999018857.SGD","SGXZ57979304.SGD","LLYZ","LU0417517546.SGD","CANC","THNR","SG9999015945.SGD","LU2023251221.USD","LU1868836757.USD","LU2271345857.HKD","LU2471134796.USD","CURE","LU1629891620.HKD","LU2602419157.SGD","BK4599","LU0323591593.USD","MEDI","LLII","LU1974910355.USD","LU1064131342.USD","LU1035775433.USD","LU1712237335.SGD","LU0823434583.USD","IYH","LU0320765992.SGD","LU0432979614.USD","IE00BKDWB100.SGD","LU2357305700.SGD","ELIS","IE00BFSS8Q28.SGD","SG9999015952.SGD","LU2087625088.SGD","LU2896262040.SGD","LU1983299246.USD","LLY","LU1814569148.SGD","LU2750360641.GBP","LU1691799644.USD","LU2237443895.HKD","WDNA","PJP","LU0122379950.USD","LU0471298777.SGD","SGXZ81514606.USD","LU1291159041.SGD","LU0385154629.USD","LU0353189763.USD","LU0456855351.SGD","LU2456880835.USD","BK4585","LU1145028129.USD","LU1868837136.USD","LU1551013425.SGD","LU1093756168.USD","LU2324357040.USD","LU2552382058.USD","LU2237443549.SGD","HRTS","IE00BFSS7M15.SGD","IE00BJJMRZ35.SGD","RXL","SG9999001176.USD","IE00B2B36J28.USD","LU1551013342.USD","LU0238689110.USD","LU2491050154.USD","BK4588","LU0109391861.USD","LU1979441026.SGD","LU0198837287.USD","LU2106854487.HKD","IE0004445015.USD","LU0006306889.USD","LU0820561818.USD","LU0820562030.AUD","IE00BN29S564.USD","LU1917777945.USD","MHIP","LU0158827781.USD","LU0640476718.USD","LU2237443978.SGD","LU0354030438.USD","LU0882574139.USD","LU2089284900.SGD","IE00B1XK9C88.USD","IE00BK4W5M84.HKD","XLV","LU0316494557.USD","LLYX","LU2237443622.USD","SG9999015986.USD","LU2063271972.USD","LU0345770993.USD","LU0094547139.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672465897","title":"Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca","url":"https://stock-news.laohu8.com/highlight/detail?id=2672465897","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672465897?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:06","pubTimestamp":1790967978,"startTime":"0","endTime":"0","summary":"Lilly says FDA approves expanded first-line CLL/SLL use for JaypircaFDA cleared Lilly’s Jaypirca (pirtobrutinib) for first-line treatment of adults with CLL/SLL with no known 17p deletion.Decision exp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL3s639g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4JS1V06.HKD","SG9999001176.USD","LU2750360997.AUD","LU0345770993.USD","LU0640476718.USD","LU2106854487.HKD","LU2357305700.SGD","LU2361045086.USD","LU2461242641.AUD","IE0002141913.USD","IE0001KFT4U8.USD","RXL","LU0345770308.USD","LU0210536198.USD","LU2324357040.USD","LU0289739699.SGD","GDOC","LU2028103732.USD","LU1974910355.USD","LU0787776722.HKD","LU0471298777.SGD","LU1280957306.USD","LU1814569148.SGD","BK4581","LU2602419157.SGD","LU0006306889.USD","WDNA","LU1720051017.SGD","LU2023250330.USD","LU0471298694.HKD","LU2111349929.HKD","LU2213496289.HKD","IE00BJJMRZ35.SGD","LU0320765059.SGD","BK4534","LU0238689110.USD","IE00BK4W5M84.HKD","LU1291159041.SGD","LU0889565916.HKD","MEDX","LU0353189763.USD","IE00BFTCPJ56.SGD","IXJ","LU1989771016.USD","IE00B1XK9C88.USD","LU2471134523.USD","LU2756315664.SGD","SGXZ31699556.SGD","LU1804176565.USD","IE00B1BXHZ80.USD","LU1983299246.USD","IE00BKPKM429.USD","LU2168564222.USD","LU2237438978.USD","SG9999013999.USD","SG9999014906.USD","LU0203202063.USD","LU0234572021.USD","LU1720051108.HKD","IE00BJT1NW94.SGD","LU2491049909.HKD","TMED","IE00B775H168.HKD","SG9999015945.SGD","SG9999001176.SGD","BK4533","AGNG","LU1691799644.USD","GB00BDT5M118.USD","LU2552382132.HKD","SG9999015986.USD","LU2468319806.SGD","BK4599","LU0964807845.USD","LU1868836591.USD","LLYZ","LU0256863902.USD","XLV","LU1127390331.HKD","SG9999018865.SGD","LU0158827948.USD","THNR","IE00BK4W5L77.USD","LU1712237335.SGD","LU0882574055.USD","SG9999015952.SGD","LU2063271972.USD","LU0097036916.USD","IE00BJJMRX11.SGD","LU2552382058.USD","LU0225283273.USD","LU0109394709.USD","IE00BFSS8Q28.SGD","LU0158827781.USD","LU1093756168.USD","LU1988902786.USD","BK4007","LU2750360641.GBP","CURE","LU2552382215.SGD","IE00BKDWB100.SGD","IE00BN29S564.USD","LU2089284900.SGD","LU0203201768.USD","LU2471134796.USD","LU1917777945.USD","LU0096364046.USD","LU0079474960.USD","LU0354030438.USD","LU0882574139.USD","LU1551013425.SGD","LU2237443622.USD","IE00B4R5TH58.HKD","LU2417539215.USD","LU1057294990.SGD","LU1979441026.SGD","LLYX","LU0820561818.USD","IE00B7KXQ091.USD","LU0943347566.SGD","FTXH","LU2087625088.SGD","LU1868837136.USD","LU0114720955.EUR","IE00BJLML261.HKD","LU0466842654.USD","LU0823416689.USD","LU0323591593.USD","LU1093756325.SGD","LU1145028129.USD","LU0417517546.SGD","LU0198837287.USD","LU2746668461.USD","IYH","LU1267930730.SGD","LU0820561909.HKD","LU2264538146.SGD","LU2756315318.SGD","LU2491050154.USD","FHLC","IE00BWXC8680.SGD","LU0786609619.USD","PPH","LU0320765992.SGD","LU0708995401.HKD","LU2236285917.USD","LU0820562030.AUD","BK4585","LU1623119135.USD","SGXZ99366536.SGD","LU1323610961.USD","LU2271345857.HKD","LU0133085943.USD","LU2112291526.USD","LU2237443978.SGD","SG9999017495.SGD","IE00B2B36J28.USD","LU0106261372.USD","LU1069344957.HKD","LLII","LU2746668974.SGD","MHIP","LU0354030511.USD","ILDR","LU1868837300.USD","LU0094547139.USD","LU2108987350.USD","LLY","LU0109391861.USD","SGXZ81514606.USD","LU0256863811.USD","LU2360106947.USD","LU0266013472.USD","LU1551013342.USD","LU1629891620.HKD","LU2491050071.SGD","LU2168564065.EUR","VHT","LU1061106388.HKD","SG9999014898.SGD","IE00BJJMRY28.SGD","LU1232071149.USD","LU2168564149.EUR","LU2361044949.HKD","BK4516","ELIS","OZEM","LU1868836757.USD","IE0004445015.USD","LU0672654240.SGD","JDOC","LU2462157665.USD","TRUH","LU0058720904.USD","IHE","IE0005OL40V9.USD","LU2168563687.JPY","BK4588","LU2237443895.HKD","LU0456855351.SGD","LU2456880835.USD","SG9999018857.SGD","IE0009355771.USD","LU1035775433.USD","LU1868836914.USD","LU2471134952.CNY","SGXZ57979304.SGD","LU0174119429.USD","LU0061475181.USD","LU2896262040.SGD","SG9999015978.USD","LU2211815571.USD","SG9999014880.SGD","LU2237443549.SGD","LU1023059063.AUD","LU2089984988.USD","LU0316494557.USD","LU0823434583.USD","LU1064131342.USD","ELIL","LU0689472784.USD","IE00BFSS7M15.SGD","LU0432979614.USD","PJP","LU0122379950.USD","LU2168564495.EUR","IE0004445239.USD","LU0683600562.USD","LU2089283258.USD","LU2237443382.USD","LU2471134879.HKD","CANC","LU2237443465.HKD","LU2361044865.SGD","LU0823434740.USD","LU2265009873.SGD","LU2023250504.SGD","LU2462591350.SGD","MEDI","HRTS","LU2023251221.USD","SG9999014914.USD","LU0353189680.USD","LU0385154629.USD","LU1366192091.USD","LU1548497426.USD","SGXZ51526630.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672874637","title":"Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll","url":"https://stock-news.laohu8.com/highlight/detail?id=2672874637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672874637?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:05","pubTimestamp":1790967939,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUA8VSLSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237443382.USD","LU2471134952.CNY","VHT","LU1868837136.USD","LU0114720955.EUR","LU0823434740.USD","SGXZ31699556.SGD","LU1814569148.SGD","SG9999014906.USD","WDNA","LU2552382132.HKD","LU1093756168.USD","LU0316494557.USD","TMED","LU1868836757.USD","LU1979441026.SGD","XLV","SG9999014914.USD","IHE","LU2750360641.GBP","IE00BWXC8680.SGD","LU0058720904.USD","LU2028103732.USD","LU2237443622.USD","LU1061106388.HKD","RXL","SG9999013999.USD","IE00B1XK9C88.USD","LU2361044865.SGD","LU0094547139.USD","LU0266013472.USD","LU1551013342.USD","LU2471134523.USD","LLYZ","LU0203201768.USD","LU0345770993.USD","CURE","LU1629891620.HKD","LU1127390331.HKD","LU1868837300.USD","SGXZ57979304.SGD","LU1868836591.USD","LU0006306889.USD","LU2237443465.HKD","IE00B775H168.HKD","LU2750360997.AUD","LU0238689110.USD","LU0323591593.USD","IYH","LU0174119429.USD","BK4588","LU0345770308.USD","LU1868836914.USD","LU1691799644.USD","LU2461242641.AUD","LU0289739699.SGD","LU2168564149.EUR","MEDI","LU0109394709.USD","LLY","LU1366192091.USD","LU1988902786.USD","IXJ","SG9999015978.USD","IE0004445239.USD","LU0256863902.USD","LU2237438978.USD","SG9999001176.USD","IE00B4R5TH58.HKD","LU0096364046.USD","LLYX","LU2089283258.USD","GB00BDT5M118.USD","LU0432979614.USD","ILDR","FHLC","LU0943347566.SGD","LU2168564065.EUR","LU2462591350.SGD","LU1035775433.USD","BK4599","LU2756315318.SGD","MHIP","LU2089284900.SGD","LU0106261372.USD","LU0882574139.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","IE00BKDWB100.SGD","LU1057294990.SGD","LU2168563687.JPY","LU0708995401.HKD","LU1551013425.SGD","LU2746668461.USD","LU0456855351.SGD","LU2896262040.SGD","LU2089984988.USD","LU2106854487.HKD","LU2063271972.USD","LU0061475181.USD","LU2471134879.HKD","LU2087625088.SGD","SG9999015986.USD","LU0964807845.USD","THNR","LU2552382058.USD","TRUH","LU0471298777.SGD","IE0004445015.USD","BK4585","LU2236285917.USD","LU0466842654.USD","IE00BKPKM429.USD","LU2168564495.EUR","LU2417539215.USD","IE00BK4W5L77.USD","LU1804176565.USD","LU2361044949.HKD","LU1267930730.SGD","LU0823434583.USD","LU1023059063.AUD","LU0320765059.SGD","LU2264538146.SGD","LU2462157665.USD","SGXZ81514606.USD","IE00BFSS8Q28.SGD","SG9999015945.SGD","AGNG","IE00BJLML261.HKD","LU0353189680.USD","IE00BJJMRX11.SGD","LU2211815571.USD","SGXZ99366536.SGD","LU1712237335.SGD","IE0001KFT4U8.USD","LU0417517546.SGD","LU0889565916.HKD","LU1069344957.HKD","BK4534","LU0203202063.USD","IE0005OL40V9.USD","SG9999014898.SGD","LU0320765992.SGD","LU2271345857.HKD","LU2491050071.SGD","LU1064131342.USD","HRTS","LU0158827948.USD","LU0354030511.USD","IE0009355771.USD","LU0385154629.USD","LU1291159041.SGD","LU1974910355.USD","IE00B1BXHZ80.USD","LU2023251221.USD","LU2491050154.USD","LU2265009873.SGD","LU2756315664.SGD","LU0109391861.USD","LU1280957306.USD","LU1983299246.USD","LU1323610961.USD","MEDX","LU2324357040.USD","LU2357305700.SGD","PJP","LU2746668974.SGD","LU0079474960.USD","LU2237443549.SGD","LU2491049909.HKD","LU2471134796.USD","LU0471298694.HKD","LU0823416689.USD","LU0198837287.USD","LU1145028129.USD","LU1989771016.USD","LU1917777945.USD","LU2456880835.USD","LU0225283273.USD","LU2023250504.SGD","LU0640476718.USD","IE00B4JS1V06.HKD","IE00B7KXQ091.USD","LU2213496289.HKD","LU2468319806.SGD","LU0097036916.USD","LU2361045086.USD","IE00BK4W5M84.HKD","IE00BFSS7M15.SGD","LU0672654240.SGD","LU2112291526.USD","GDOC","SG9999001176.SGD","BK4516","LU0256863811.USD","LU2023250330.USD","LU2237443895.HKD","LLII","LU2360106947.USD","LU2108987350.USD","LU1623119135.USD","ELIS","LU0210536198.USD","LU0787776722.HKD","PPH","SG9999017495.SGD","LU0820561818.USD","BK4581","LU0820562030.AUD","ELIL","LU2111349929.HKD","LU1548497426.USD","LU0786609619.USD","CANC","LU2168564222.USD","IE00B2B36J28.USD","LU1720051108.HKD","SG9999018865.SGD","BK4007","IE00BJT1NW94.SGD","LU2552382215.SGD","LU2237443978.SGD","IE0002141913.USD","LU0122379950.USD","SGXZ51526630.SGD","BK4533","IE00BN29S564.USD","LU2602419157.SGD","SG9999018857.SGD","SG9999014880.SGD","LU0234572021.USD","LU1720051017.SGD","LU0158827781.USD","SG9999015952.SGD","LU0133085943.USD","IE00BFTCPJ56.SGD","JDOC","LU0354030438.USD","LU0820561909.HKD","IE00BJJMRY28.SGD","FTXH","LU0683600562.USD","LU1093756325.SGD","LU1232071149.USD","OZEM","LU0353189763.USD","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672034743","title":"Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672034743","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672034743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:05","pubTimestamp":1790960723,"startTime":"0","endTime":"0","summary":"Legend Biotech's (LEGN) multiple myeloma therapy Carvykti is facing growing competitive pressure as Gilead Sciences' (GILD) anito-cel approaches a potential approval and Johnson & Johnson's (JNJ) Tec-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBBQ","IE00B42XCP33.USD","BK4504","JNJ","LU0545039389.USD","MEDI","GDOC","BIB","LU1162221912.USD","LU0320765992.SGD","IE00BLSP4452.SGD","VHT","BMED","FHLC","LU1585245621.USD","LU0345769631.USD","BK4550","LABU","LU0859254822.USD","PJP","XBI","LU0345770308.USD","TRUH","FTXH","LU0889566641.SGD","TMED","XLV","IBB","IE0034235303.USD","TBXU","MEDX","GILD","IHE","JDOC","CANC","LU1261432733.SGD","LU1221951046.USD","MEMS","IYH","IE00BLSP4239.USD","LEGN","IXJ","BBH","LU0426417589.USD","SG9999001440.SGD","IE00BKVL7J92.USD","LU1057294990.SGD","RXL","LU0545562505.USD","LU2129689605.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672743169","title":"AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672743169","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672743169?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958623,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s latest study, NCT05317494, tracks how its leukemia drug Venetoclax wor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-venetoclax-aml-study-in-greece-what-the-latest-update-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-venetoclax-aml-study-in-greece-what-the-latest-update-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2125909247.SGD","IE00BN8TJ469.HKD","LU1732799900.SGD","IE00BSNM7G36.USD","VHT","LU0170899867.USD","SG9999011175.SGD","IYH","LU1934455863.HKD","RXL","ABBV","LU0985320562.USD","LU1244550494.USD","LU1989771016.USD","LU1839511570.USD","LU0310800379.SGD","FHLC","LU2133065610.SGD","LU0289739699.SGD","LU0942090050.USD","TRUH","LU2129689605.HKD","LU0965509010.AUD","GLAM","LU0310799852.SGD","IE00BLSP4452.SGD","ISBC","MEDX","LU0198837287.USD","LU1989772840.SGD","LU0289961442.SGD","FTXH","LU0395794307.EUR","PJP","LU0029864427.USD","XLV","JDOC","IXJ","IE00BDGV0183.EUR","IE00BVYPNW00.USD","LU0234572021.USD","AGNG","IE0002270589.USD","PPH","LU1023059063.AUD","IE00B19Z3581.USD","LU2237443549.SGD","IE00B42XCP33.USD","LU2023251221.USD","LU2129689514.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672339714","title":"Correction: Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2672339714","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672339714?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:22","pubTimestamp":1790943727,"startTime":"0","endTime":"0","summary":"Corteva  said Thursday that a federal court denied California's request to temporarily block the planned separation of its seed business into a new publicly traded company, Vylor .In a separate announcement, Vylor said it completed its separation from Corteva and will begin trading as an independent public company on the New York Stock Exchange.Corteva shares slumped 84% as intraday trading volume catapulted to nearly 63.5 million from a daily average of about 4.45 million.Foghorn Therapeutics  and Eli Lilly  have decided not to advance FHD-909  into the clinical development expansion phase after reviewing clinical data from a phase 1 dose escalation trial.Foghorn shares sank 20% as intraday trading volume soared to nearly 11.8 million from a daily average of roughly 380,000.Paramount Skydance  CEO David Ellison has asked CNN CEO Mark Thompson to continue after Paramount completes its acquisition of Warner Bros. Discovery , The Wall Street Journal reported Thursday, citing people famil","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","IE00B2B36J28.USD","PYZ","LU0823434583.USD","LU0316494557.USD","LU0256863902.USD","LU0109394709.USD","IE00BFSS8Q28.SGD","IE00BN29S564.USD","LU0225283273.USD","LU2089283258.USD","LU2211815571.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU2271345857.HKD","LU0109391861.USD","LU2023251221.USD","PBJ","SG9999002521.SGD","SG9999014898.SGD","LU2471134952.CNY","CURE","LU2750360641.GBP","WBD","FTXH","LU0353189680.USD","LU0823434740.USD","LU0122379950.USD","ELIS","LU0820561818.USD","SG9999018865.SGD","LU0094547139.USD","LU0477156953.USD","SG9999013999.USD","LU2168564495.EUR","LU0612318971.USD","IE00B775H168.HKD","IE00BFSS7M15.SGD","VHT","LU0079474960.USD","IYH","LU2746668461.USD","LU2756315318.SGD","LU1868836591.USD","LU2087625088.SGD","LU2168564065.EUR","BK4585","LU0006306889.USD","LU0353189763.USD","LU0354030511.USD","LU1979441026.SGD","BK4139","LU2462157665.USD","LU1917777945.USD","LU0654597011.USD","LU1035775433.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU0345781412.USD","LU1366192091.USD","SKYD","IE00B4R5TH58.HKD","LU1201861249.SGD","ILDR","LU0256863811.USD","BK4581","BK4125","SG9999018857.SGD","SGXZ31699556.SGD","LLYX","LU1548497426.USD","LU2552382132.HKD","WDNA","LU1323610961.USD","LU2896262040.SGD","FHLC","LU1145028129.USD","LU0203202063.USD","IE00BJLML261.HKD","LU0097036916.USD","SG9999001176.USD","LU0471298777.SGD","LU1720051017.SGD","LU2602419157.SGD","FTAG","LU2552382058.USD","IE00BKDWB100.SGD","LU1974910355.USD","LU1291159041.SGD","LU2023250330.USD","LU0266013472.USD","LU2023250504.SGD","LLII","BK4093","LU0630314457.HKD","LU2111349929.HKD","LU0823416689.USD","IXJ","LU0889565916.HKD","LU0964807845.USD","PPH","LU0417517546.SGD","LU0648001328.SGD","IE00B4JS1V06.HKD","LU0203201768.USD","LLYZ","MEDX","LU0345770308.USD","LU0689472784.USD","LU2456880835.USD","LU2211817866.USD","PJP","LU0130517989.USD","LU2491050154.USD","LU1868837136.USD","LU1983299246.USD","LU1093756325.SGD","BK4533","LU1551013342.USD","RXL","LU0289739699.SGD","LU0787776722.HKD","THNR","VYLR","IE00BKPKM429.USD","IE0004445239.USD","LU1064131342.USD","IE00BJJMRY28.SGD","LU0106261372.USD","LU0323591593.USD","LU1232071149.USD","LU2237443978.SGD","HRTS","LU0130102774.USD","LU0320765992.SGD","IE00BK4W5L77.USD","LU2756315664.SGD","BK4598","SG9999001176.SGD","LU2028103732.USD","LU1061106388.HKD","LU1551013425.SGD","ELIL","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0943347566.SGD","LU1868836914.USD","IE00BK4W5M84.HKD","LU1804176565.USD","MHIP","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0471298694.HKD","LU2361045086.USD","LU0096364046.USD","LU1506573853.SGD","LU1720051108.HKD","LU0385154629.USD","LU0882574139.USD","IE0005OL40V9.USD","LU2361044949.HKD","LU2237438978.USD","SG9999014906.USD","JDOC","BK4599","SGXZ99366536.SGD","LU2461242641.AUD","BK4534","LU2324357040.USD","LU2112291526.USD","BK4588","LU0149725797.USD","BK4007","LU2750360997.AUD","LU0980610538.SGD","LU1127390331.HKD","LU2106854487.HKD","LU2236285917.USD","IE00BJJMRX11.SGD","LU0320765059.SGD","IE0004445015.USD","LU0300736062.USD","LU1629891620.HKD","CTVA","CANC","LU0158827948.USD","LU0238689110.USD","LU0345770993.USD","LU1868836757.USD","LU1691799644.USD","SGXZ81514606.USD","LU2468319806.SGD","IE00B7KXQ091.USD","LU0672654240.SGD","BK4516","LU0882574055.USD","PSKY","TRUH","LU0466842654.USD","LU0786609619.USD","IE00B1BXHZ80.USD","LU1280957306.USD","LU2089984988.USD","LU2237443622.USD","LU2746668974.SGD","LU0820562030.AUD","LU1712237335.SGD","LU1093756168.USD","LU0114720955.EUR","LU0058720904.USD","LU2213496289.HKD","LU1988902786.USD","LU2491049909.HKD","AGNG","LU1430597077.USD","SG9999015986.USD","TMED","LU2168564222.USD","SGXZ51526630.SGD","LU0158827781.USD","LU0234572021.USD","LU0061475181.USD","LU0174119429.USD","LU0354030438.USD","LU2237443465.HKD","LU1057294990.SGD","LU2237443549.SGD","SG9999015978.USD","LU1989771016.USD","LU2471134523.USD","VEGI","LU0820561909.HKD","LU0345780950.USD","LU1267930730.SGD","LU0133085943.USD","SG9999014880.SGD","IE0002141913.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2168564149.EUR","LU2417539215.USD","LU0198837287.USD","LU2471134796.USD","SG9999015945.SGD","LU0612318385.USD","LU0210536198.USD","LU2491050071.SGD","IE00B1XK9C88.USD","LU2237443382.USD","LLY","GDOC","IE00BWXC8680.SGD","LU2462591350.SGD","SGXZ57979304.SGD","XLV","LU2089284900.SGD","LU0300736492.USD","LU2360106947.USD","FHTX","SG9999014914.USD","GB00BDT5M118.USD","LU2237443895.HKD","MEDI","LU2357305700.SGD","LU2471134879.HKD","SG9999017495.SGD","LU2265009873.SGD","LU0683600562.USD","LU0708995401.HKD","LU0432979614.USD","LU1623119135.USD","OZEM","SG9999015952.SGD","LU1868837300.USD","BK4108","LU1023059063.AUD","IHE","LU2552382215.SGD","KROP","BK4535","IE0001KFT4U8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672163957","title":"Abogen announces licensing, option agreement with Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672163957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672163957?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:10","pubTimestamp":1790935812,"startTime":"0","endTime":"0","summary":"Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, announced that it has entered into a licensing and option agree...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","FHLC","AGNG","BBP","BBC","SYNB","XT","JDOC","BK4588","LNGR","IBB","BK4585","BK4139","RSPH","FWD","IEIH","RNA","IE0009354923.USD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672716311","title":"Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672716311","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672716311?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:05","pubTimestamp":1790935529,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced new two-year data from the Phase 3 ICONIC-TOTAL study demonstrating the positive impact of ICOTYDE on high-impact plaqu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-announces-two-year-data-from-phase-3-iconic-total-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-announces-two-year-data-from-phase-3-iconic-total-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","LU0640476718.USD","LU2468319806.SGD","JDOC","IE00B19Z3B42.SGD","FHLC","LU2430703251.USD","RXL","TRUH","LU0234570918.USD","IE00BDGV0183.EUR","LU1043141396.HKD","GDOC","JNJ","LU0738911758.USD","LU2236285917.USD","XLV","IHE","LU2505996509.AUD","BK4581","BK4588","LU0203345920.USD","IE00B2B36J28.USD","LU1732800096.USD","BK4534","LU2471134952.CNY","LU2896262040.SGD","SGXZ57979304.SGD","MEDX","BMED","LU0426412945.USD","IXJ","PJP","IE0002270589.USD","BK4592","LU1551013425.SGD","LU2417539215.USD","LU1066053197.SGD","LU1551013342.USD","SG9999013999.USD","LU1496350502.SGD","VHT","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","LU0162691827.USD","FTXH","SG9999002224.SGD","IE000WAW04H5.SGD","LU0466842654.USD","LU0994945656.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715109","title":"Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715109","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715109?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:01","pubTimestamp":1790935267,"startTime":"0","endTime":"0","summary":"Johnson & Johnson says ICOTYDE sustains psoriasis skin clearance through 2 years in Phase 3 ICONIC-TOTAL studyJohnson & Johnson disclosed new two-year Phase 3 ICONIC-TOTAL results for ICOTYDE (icotrok","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8bWfkV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","LU1732800096.USD","SG9999002224.SGD","LU2430703251.USD","LU1629891620.HKD","IYH","XLV","LU0994945656.USD","LU1674673691.USD","LU2456880835.USD","LU2417539215.USD","LU0426412945.USD","IHE","LU0820561818.USD","IE0034235303.USD","LU1061106388.HKD","SG9999001440.SGD","RXL","IE00BLSP4452.SGD","TRUH","LU2129689605.HKD","FTXH","IXJ","LU0738911758.USD","IE00BSNM7G36.USD","PJP","IE0009355771.USD","BMED","MEDX","LU0072461881.USD","LU1066051225.USD","BK4592","LU0545039389.USD","IE00BBT3K403.USD","LU0234572021.USD","VHT","LU1430594728.SGD","LU1043141123.HKD","JDOC","LU1066051811.HKD","LU1043141396.HKD","GDOC","IE00B4R5TH58.HKD","LU2896262040.SGD","LU0162691827.USD","IE0000B7K699.USD","FHLC","SG9999001176.USD","IE00BJT1NW94.SGD","LU2347655156.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672971590","title":"J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112","url":"https://stock-news.laohu8.com/highlight/detail?id=2672971590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672971590?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0057025933.USD","LU1551013425.SGD","LU1221951046.USD","MEDX","LU2129689605.HKD","FTXH","IE0001KFT4U8.USD","TRUH","LU1121112475.USD","LU1162221912.USD","LU0882574055.USD","BK4581","IHE","VHT","LU0426417589.USD","SGXZ80539844.SGD","LU0820562030.AUD","LU1061106388.HKD","IE00B19Z3581.USD","GDOC","LU0162691827.USD","BK4568","FHLC","LU0795875169.SGD","LU1989771016.USD","JNJ","IE00B4R5TH58.HKD","BMED","LU0912757837.SGD","LU1551013342.USD","LU0320765646.SGD","XLV","IXJ","LU1935042991.SGD","LU0820561909.HKD","JDOC","LU2592432038.USD","IYH","LU0234572021.USD","PJP","LU1496350502.SGD","LU2347655156.SGD","LU1066051498.USD","LU1674673691.USD","LU0426412945.USD","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","LU0072461881.USD","LU2471134879.HKD","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672900715","title":"Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~","url":"https://stock-news.laohu8.com/highlight/detail?id=2672900715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672900715?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FHLC","XLV","LU0234570918.USD","LU0889566641.SGD","IXJ","JDOC","IE00BKVL7J92.USD","LU0795875086.SGD","LU1989771016.USD","FTXH","VHT","LU1003077747.HKD","LU1221951129.SGD","BK4550","IE00BVYPNV92.GBP","IE00BGHQF631.EUR","LU0070217475.USD","LU0203347892.USD","BK4568","IHE","LU1674673691.USD","BK4581","IE00BVYPNW00.USD","IYH","LU0820561909.HKD","LU0122379950.USD","LU0472753341.HKD","LU2750360641.GBP","LU0511384066.AUD","BMED","RXL","IE00BSNM7G36.USD","IE0009355771.USD","LU0203345920.USD","LU0792757196.USD","LU0820562030.AUD","LU1066053197.SGD","JNJ","MEDX","LU1551013342.USD","LU1228905037.USD","GDOC","LU1430594728.SGD","IE00BDGV0183.EUR","PJP","LU1267930813.SGD","TRUH","LU1066051225.USD","LU0882574055.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715972","title":"J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715972?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","LU0345770993.USD","LU1074936037.SGD","IHE","LU1267930813.SGD","FTXH","IXJ","BMED","JDOC","IE000MB6IJN5.SGD","LU1983299246.USD","GDOC","TRUH","LU0882574055.USD","LU1145028129.USD","LU0203347892.USD","LU2471134879.HKD","VHT","LU0210528500.USD","BK4581","IYH","LU2456880835.USD","IE000F7OJYX1.SGD","LU1914381329.SGD","FHLC","LU0162691827.USD","BK4588","LU0072461881.USD","LU0545562505.USD","LU2129689514.USD","PJP","RXL","IE000BZT7R73.USD","LU0820562030.AUD","XLV","IE00BFTCPJ56.SGD","IE000M9KFDE8.USD","LU0345769128.USD","JNJ","LU0964807845.USD","SG9999002232.USD","LU1221951129.SGD","LU2505996681.GBP","LU1732800096.USD","LU1043141123.HKD","LU1551013425.SGD","IE00BN8TJ469.HKD","IE00B1BXHZ80.USD","LU1506573853.SGD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672171597","title":"J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672171597","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672171597?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0795875086.SGD","LU0070217475.USD","LU1003077747.HKD","LU0792757196.USD","LU0820562030.AUD","LU0203345920.USD","LU1674673691.USD","BK4550","LU0882574055.USD","LU0472753341.HKD","LU0122379950.USD","IHE","LU0234570918.USD","JNJ","XLV","LU1221951129.SGD","BK4581","LU1430594728.SGD","GDOC","LU2750360641.GBP","VHT","LU0889566641.SGD","IE00BVYPNW00.USD","FTXH","LU0820561909.HKD","TRUH","IYH","LU1066053197.SGD","MEDX","BK4568","LU0203347892.USD","FHLC","IXJ","IE00BDGV0183.EUR","IE00BGHQF631.EUR","LU1066051225.USD","LU0432979614.USD","LU0511384066.AUD","PJP","LU1551013342.USD","RXL","JDOC","IE00BKVL7J92.USD","IE00BVYPNV92.GBP","LU1267930813.SGD","LU1228905037.USD","LU1989771016.USD","IE00BSNM7G36.USD","IE0009355771.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","SG9999014880.SGD","IE00BFXG1179.USD","KURE","BK1587","LU2023250504.SGD","LU2293690249.USD","IE00B1BXHZ80.USD","LU0827474353.SGD","SG9999015945.SGD","LU0784383803.USD","LU1366192091.USD","LU0124676726.USD","LU1481599808.USD","IE00B19Z3581.USD","LU0320765646.SGD","IE00B3PB1722.GBP","LU2750360997.AUD","BK4551","LU0390134368.USD","LU1035775433.USD","LU1487256676.USD","LU0661504455.SGD","LU0348827113.USD","LU1280957306.USD","LU1267930227.SGD","LU2361044949.HKD","LU2399975544.HKD","LU0057025933.USD","LU0106261372.USD","LU0306806265.USD","LU2125909593.SGD","LU1670628061.USD","IE00B543WZ88.USD","BK0239","MHIP","LU0501845795.SGD","LU2433249047.HKD","BK4592","LU2488822045.USD","HCM","LU1883839398.USD","LU0348784397.USD","LU0353189680.USD","LU0965508806.USD","IE0005OL40V9.USD","LU0887340254.USD","LU0203345920.USD","LU0321505439.SGD","ILDR","LU1732799900.SGD","LU1302929846.USD","LU0820561818.USD","LU0203201768.USD","LU0889566641.SGD","600276","LU0348825331.USD","LU1051770623.HKD","LU1496350171.SGD","SG9999014559.SGD","LU2097828557.USD","BK0196","LU0969580561.USD","LU0417516738.SGD","LU1496350502.SGD","LU2168564495.EUR","IXJ","VHT","LU0526926950.USD","LU0244354667.USD","01093","LU0079474960.USD","LU1328277881.USD","LU2462157665.USD","LU0354030438.USD","LU1188198961.HKD","IE00B42XCP33.USD","LU0882574139.USD","LU2097828474.EUR","SGXZ31699556.SGD","LU1781817850.SGD","IE00BLSP4239.USD","LU0708994859.HKD","LU1934455277.USD","BK4568","LU2539964713.USD","LU1718418525.SGD","LU0889565916.HKD","LU0128525929.USD","LU1997245094.SGD","IE00BKDWB100.SGD","LU0964806797.USD","LU2360032135.SGD","NVOH","IE0008369823.USD","NVO","IYH","LU1226287529.USD","LU2108987350.USD","LU0211331839.USD","LU0011850046.USD","LU1868836591.USD","LU2289578879.USD","NVOX","SG9999002232.USD","IE00BZ1G4Q59.USD","LU1153584641.USD","LU0943347566.SGD","SG9999001440.SGD","SG9999001176.USD","LU0289961442.SGD","LU0047473722.SGD","LU1969619763.USD","IE00BDGV0183.EUR","LU2324357040.USD","IE00B031HY20.USD","IE00BK4W5M84.HKD","LU2168564222.USD","ELIL","LU1064131003.USD","IHE","LU0211326755.USD","LU2495084118.USD","LU0980610538.SGD","LU0353189763.USD","LU1989772840.SGD","LU1839511570.USD","LU0345777659.USD","HRTS","LU0964807845.USD","LU0640478417.SGD","LU0225284248.USD","LU2063271972.USD","IE00B2B36J28.USD","LU0965509283.SGD","LU2091194634.USD","LU2552382058.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2461242641.AUD","SGXZ57979304.SGD","IE0002141913.USD","BK4559","LU0053666078.USD","LU2646069778.SGD","IBBQ","LU0823434740.USD","LU1670627923.USD","LU2756315318.SGD","LU2028103732.USD","LU1960683339.HKD","LU2125154778.USD","BK1589","BK1588","LU0348767384.USD","LU0061475181.USD","IE00BKPKM643.USD","LU1003076772.USD","BK4578","LU0784385840.USD","LU0114720955.EUR","LU0405327148.USD","LU0234570918.USD","LU0784385170.HKD","LU1226288253.USD","IE0008368742.USD","LU0256863811.USD","LU0949170772.SGD","BK0028","PPH","GLAM","LU2355687059.USD","LU1894683264.USD","LU1988902786.USD","SG9999015358.SGD","LU0472753341.HKD","LU1032466523.USD","IE000BZT7R73.USD","LU1145028129.USD","LU2097828805.USD","LU0976567544.SGD","LU2491049909.HKD","LU1670711040.USD","SG9999015986.USD","LU1046234339.USD","688331","LU0502904849.HKD","LU0405327494.USD","LU1868836914.USD","LU0171276677.USD","LU1236620750.USD","LU0634319403.HKD","LU1997244956.HKD","SG9999011175.SGD","LU2129689605.HKD","IE00BJT1NW94.SGD","LU0348766576.USD","LU0432979614.USD","LU1400636574.HKD","LU1228905540.USD","LU1309081286.SGD","REGN","MEDI","BK4585","IE00BLSP4452.SGD","LU2125909247.SGD","LU2242646821.SGD","SG9999017495.SGD","LU0237698245.USD","IE00BWXC8680.SGD","LU0912757837.SGD","LU1023059063.AUD","LU1153585028.USD","688506","LU1993786604.SGD","LU1894683348.USD","LU0130517989.USD","LU0069063385.USD","IE00B3M56506.USD","LU1228905037.USD","LU1064927863.SGD","LU0345770308.USD","LU1244550221.USD","LU1941712264.USD","LU1655091616.SGD","GSK.UK","LU1355424745.HKD","LU1863844749.USD","TMED","BK5011","BK0183","LU2750360641.GBP","SGXZ51526630.SGD","LU0047473722.EUR","LU0072913022.USD","LU2237443549.SGD","LU0545562505.USD","LU2596442595.SGD","LU2471134879.HKD","LU2293690082.USD","IE0002270589.USD","LU0162691827.USD","IE00BZ08YS42.EUR","LU0354030511.USD","LU0154236417.USD","LU0267386448.USD","LU1863844665.USD","LU0757432116.USD","LU2089283258.USD","LU2357627491.SGD","LU0067412154.USD","LU0965509101.SGD","LU1580142542.USD","LLY","LU0795875086.SGD","LU1868837300.USD","IE00BWDBJ516.SGD","LU1623119135.USD","IE00BK4W5L77.USD","LU1226287875.USD","LU0320765992.SGD","LU0456855351.SGD","LU2362540622.SGD","SG9999014906.USD","AGNG","LU0972486137.USD","LU1003077747.HKD","LU1481600234.SGD","MRK","LU0070302665.USD","CURE","LU1069347547.HKD","LU1255011170.USD","LU0861579265.USD","LU0640476718.USD","LU0557290698.USD","LU3187612489.SGD","LU2129689514.USD","LU1923622614.USD","LU1084165304.USD","IE00B4JS1V06.HKD","BNTX","LU2476274308.USD","LU1201861249.SGD","LU2148510915.USD","PJP","XLV","LU0256863902.USD","LU2242652126.USD","LU0689472784.USD","LU1720051108.HKD","LU1244550577.SGD","LU0868494617.USD","SG9999015952.SGD","LU2097828631.EUR","LU2237443382.USD","LU1291159041.SGD","LU0942090050.USD","LU2111349929.HKD","IE00BBT3K403.USD","LU0310800379.SGD","LU2023250843.SGD","LU1267930490.SGD","LU0345777147.USD","LU1699723380.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","SG9999003800.SGD","LU2746668974.SGD","LU0316494557.USD","LU2039709279.SGD","SG9999018865.SGD","03692","IE000M9KFDE8.USD","LU2089984988.USD","LU0098860793.USD","LU0133085943.USD","ABBV","LU1941712348.USD","LU1983299246.USD","LU1273509221.SGD","BK4139","LU1670711123.USD","RHHBY","BK4535","LU1116320901.HKD","LU2756315664.SGD","LU0266013472.USD","SG9999001176.SGD","LU2362541513.USD","LU1037948897.HKD","LU2456880835.USD","LU2087625088.SGD","BK1515","LU2129689431.USD","LU1152091754.HKD","LU0161305163.EUR","LU0130102774.USD","IE000WAW04H5.SGD","LU0052756011.USD","LU1820825898.SGD","LU0499090636.EUR","SG9999014567.USD","FTXH","LU0265550946.USD","LU0171293334.USD","LLII","LU2476274720.SGD","LU0868494708.USD","BK1521","LU1548497426.USD","LU1880407215.USD","LU2471134796.USD","SGXZ99366536.SGD","BK4533","LU2211815571.USD","RXL","LU2552382215.SGD","LU1629891620.HKD","IE00BKPKM429.USD","LU1712237335.SGD","LU1814569148.SGD","SG9999004220.SGD","LU1008478684.HKD","LU1116320737.USD","TRUH","IE00BFSS7M15.SGD","LU1226287792.SGD","MEDX","LU2328871848.SGD","LU1267930813.SGD","LU1104425308.USD","LU0417517546.SGD","LU0203347892.USD","LU0077335932.USD","IE00BZ08YT58.USD","LU0210536198.USD","LU0238689110.USD","LU1261432733.SGD","LU0385154629.USD","LU0882574055.USD","LU1934455194.USD","IE0009355771.USD","LU0820561909.HKD","BK1593","BK4566","LU2133065610.SGD","LU2746668461.USD","LU0158827781.USD","LU2491050154.USD","HK0000165453.HKD","LU1585245621.USD","LU1098665638.USD","IE0000B7K699.USD","LU1670710588.SGD","IE00B7KXQ091.USD","LU0889565080.SGD","LU2023250330.USD","01276","LU0820562030.AUD","LU2097828714.EUR","LU0029864427.USD","LU2279689827.SGD","LU1831875114.USD","BK1161","LU0058720904.USD","LU1035773651.USD","LU1064130708.USD","LU0225771236.USD","LU0471298694.HKD","LU0553294199.USD","LU0607220059.USD","BK1574","IE00BGHQF631.EUR","LU0466842654.USD","LU0211328371.USD","SG9999002224.SGD","LU2242644610.SGD","SG9999014575.USD","LU0823434583.USD","LU0672654240.SGD","LU2347655073.USD","AZN.UK","LU2023251221.USD","LU2168564065.EUR","LU0128525689.USD","LU1328615791.USD","LU0289739699.SGD","LU2357305700.SGD","LU2360106947.USD","IE0004445239.USD","LU0109391861.USD","LU1226288170.HKD","LU0198837287.USD","LU0823399737.USD","LU1267930730.SGD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LLYZ","PFE","LU0648001328.SGD","LU0997586432.USD","LU1400636657.SGD","LU0314109678.HKD","LU2087621335.USD","GDOC","LU0708995401.HKD","LU1400636491.USD","01530","LU2271345857.HKD","LU0158827948.USD","LU0149534421.HKD","LU0315179316.USD","LU0985320562.USD","LU1232071149.USD","BK0188","LU1720051017.SGD","LU2106854487.HKD","LU1794554557.SGD","LU0072461881.USD","LU0987226296.USD","LU1974910355.USD","BK4588","LU1152091168.USD","LU0211326839.USD","LU1807302812.USD","LU1037948541.HKD","LU0957799991.USD","BK0060","LU0786609619.USD","LU1934455863.HKD","LU0348783233.USD","LU0140636845.USD","LU1035777561.USD","LU0006306889.USD","LU0265550359.USD","LU1691799644.USD","LU1829250122.USD","IE00BZ08YR35.GBP","IE00BJLML261.HKD","LU2347655156.SGD","LU2168563687.JPY","ELIS","LU0857590862.USD","LU1551013342.USD","LU0540923850.HKD","LU0792757196.USD","LU1093756325.SGD","LU2168564149.EUR","LU0880133367.SGD","LU1127390331.HKD","IE000SO60NU8.SGD","LU0738911758.USD","IE0004445015.USD","LU1066051225.USD","LU0575583348.USD","LU1301847155.USD","LU2237443465.HKD","LLYX","IE00BFSS8Q28.SGD","LU1202635105.USD","LU1066051498.USD","LU2114397693.USD","LU1146622755.USD","LU0094547139.USD","LU0920783379.SGD","IE00BKVL7J92.USD","LU0174119429.USD","LU1917777945.USD","LU0463099449.HKD","LU2264538146.SGD","LU2237443622.USD","LU1720050803.USD","LU2361045086.USD","LU0455707207.USD","BK4516","LU0289739343.SGD","LU0096364046.USD","LU1670756490.USD","LU0545039389.USD","IE000MB6IJN5.SGD","LU0097036916.USD","LU1323610961.USD","LU0225283273.USD","09995","LU0109981661.USD","LU0170899867.USD","BK4007","LU1078025761.USD","SG9999018857.SGD","LU1069344957.HKD","LU2236285917.USD","LU0960981461.USD","LU0949170426.SGD","LU2468319806.SGD","IE00B5MMRT66.SGD","IE00BVYPNW00.USD","LU1019632923.USD","LU1066053197.SGD","LU1015430645.USD","IE00BQJZX424.USD","01801","LU1066051811.HKD","WDNA","LU1868837136.USD","IBB","IE000F7OJYX1.SGD","CANC","BK1191","OZEM","LU1645745479.HKD","LU0471298777.SGD","LU2778985437.USD","LU1929549753.HKD","LU1430594728.SGD","THNR","IE00BN8TJ469.HKD","LU1989771016.USD","LU0920840948.USD","BK4550","LU1061106388.HKD","LU1997245177.USD","IE00B19Z3B42.SGD","SG9999013999.USD","LU1074936037.SGD","SGXZ81514606.USD","03933","LU0310799852.SGD","LU0965509010.AUD","LU1236620834.HKD","LU0234572021.USD","LU0689626769.HKD","LU0208291251.USD","NVOC","BK4534","LU0395794307.EUR","LU0417516902.SGD","LU1244550494.USD","BBH","LU0320765489.SGD","LU1732800096.USD","SG9999014898.SGD","LU2112291526.USD","LU1813983027.USD","LU1119994496.HKD","LU1046248800.SGD","LU1162221912.USD","LU0823416689.USD","LU1196032939.SGD","LU1093756168.USD","LU0787776722.HKD","LU1019634622.SGD","02096","GB00BDT5M118.USD","IE00BVYPNV92.GBP","LU0971552830.HKD","LU0795875169.SGD","LU0971552673.USD","LU0211327993.USD","LU0496365809.HKD","SG9999015978.USD","BK0012","LU1064131342.USD","LU2580892862.HKD","IE00B3T34201.USD","LU1880407132.USD","SG9999014542.SGD","03165","LU1989772923.USD","BK4532","LU2265009873.SGD","PAWZ","LU0511384066.AUD","IE00B775H168.HKD","BMED","BK1583","LU2602419157.SGD","IE00BJJMRX11.SGD","LU2580892789.USD","LU0683600562.USD","SG9999014914.USD","BK4599","IE00B1XK9C88.USD","IE00BPRC5H50.USD","SG9999015341.SGD","LU2237443978.SGD","LU0985481810.HKD","LU2471134523.USD","BMY","LU0417516571.SGD","LU0326950275.SGD","LU2417539215.USD","LU2462591350.SGD","LU2361044865.SGD","LU1170363599.USD","LU0561508036.HKD","LU1868836757.USD","LU1670710661.SGD","SMMT","LU0963555726.SGD","00013","LU2896262040.SGD","LU1961090484.USD","LU1979441026.SGD","LU0997586515.USD","LU2237438978.USD","LU1804176565.USD","IE00BN29S564.USD","IE0034235071.USD","LU0203202063.USD","LU0323591593.USD","LU0784384876.USD","LU2089284900.SGD","LU2237443895.HKD","BK4548","LU1571399168.USD","LU0321505868.SGD","NVS","LU0306807586.USD","IE00BSNM7G36.USD","09926","LU2213496289.HKD","LU1951186391.HKD","LU2471134952.CNY","LU0477156953.USD","BK4581","LU0726765562.USD","FHLC","LU0348735423.USD","TBXU","IE0034235188.USD","LU0345770993.USD","LU0310800965.SGD","JDOC","LU2125154935.USD","LU0859254822.USD","LU2362541273.HKD","LU2491050071.SGD","LU2552382132.HKD","LU0122379950.USD","LU1267930573.SGD","IE00BJJMRY28.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672137097","title":"Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672137097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672137097?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:35","pubTimestamp":1790933700,"startTime":"0","endTime":"0","summary":"0934 GMT - Sanofi and Regeneron Pharmaceuticals' potential successors to blockbuster medicine Dupixent might lag behind rival drugs Pfizer and AbbVie are developing, Citi analysts say in a research note. The new experimental drugs Sanofi and Regeneron will jointly develop under their alliance focus solely on extending the dosing interval of Dupixent without compromising efficacy or tolerability, but there is no expectation of a superior performance, Citi says. This suggests those medicines might struggle to compete with Pfizer's tilrekimig and AbbVie's zumilokibart, both of which have shown potential for better efficacy in midstage trials, according to Citi. Moreover, it might be challenging for Sanofi and Regeneron to get reimbursement for those drugs from healthcare payers after copycat versions of Dupixent become available, the analysts add. Sanofi shares fall 3.4%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU0211327993.USD","LU2106854487.HKD","LU0965509283.SGD","ABBV","JDOC","LU1037948541.HKD","IXJ","TBXU","PJP","LU0098860793.USD","LU0795875169.SGD","IBBQ","LU0949170772.SGD","VHT","LU2112291526.USD","XLV","LU0158827948.USD","LU1244550577.SGD","SNY","FTXH","GLAM","SNYNF","LU0069063385.USD","LU0057025933.USD","MEDX","LU1720051108.HKD","AGNG","BBH","FHLC","TRUH","LU1883839398.USD","BK4585","LU0417517546.SGD","IE00BJT1NW94.SGD","REGN","OZEM","LU0128525929.USD","LU2347655073.USD","BK4599","IBB","LU1917777945.USD","IYH","LU0029864427.USD","LU0203347892.USD","PPH","PFE","LU2133065610.SGD","RXL","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672790916","title":"Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2672790916","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672790916?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:57","pubTimestamp":1790927874,"startTime":"0","endTime":"0","summary":"UPDATE 3-Novartis strikes up to $7.8 billion mRNA deal with China's AbogenOct 2 (Reuters)-Chinese biotech company Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Nov","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1814569148.SGD","GNOM","PPH","IDNA","VHT","PAWZ","LU0162691827.USD","AZN.UK","BK4007","LU1051770623.HKD","GDOC","IE00BKPKM643.USD","LGHT","FTXH","WDNA","IE00BLSP4239.USD","LU0171293334.USD","LU0942090050.USD","LU1291159041.SGD","LU1430594728.SGD","LU1989771016.USD","LU0011850046.USD","03165","LU2112291526.USD","FHLC","MRNA","LU0070302665.USD","MRNY","BMED","IHE","IXJ","LU1880407132.USD","XLV","LU0098860793.USD","LU0976567544.SGD","LU1261432733.SGD","SG9999015358.SGD","TRUH","LU0757432116.USD","HRTS","JDOC","IYH","LU0920783379.SGD","MRK","LU0823416689.USD","LU2106854487.HKD","RXL","MRNX","LU0203347892.USD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672916767","title":"Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672916767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672916767?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:28","pubTimestamp":1790890080,"startTime":"0","endTime":"0","summary":"DJ Perrigo Co. PLC Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  slid 5.01% to $14.02 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's fourth consecutive day of losses.Perrigo Co. PLC closed 38.10% below its 52-week high of $22.65, which the company reached on October 3rd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Procter & Gamble Co.  fell 0.92% to $143.95, and Abbott Laboratories  fell 2.17% to $96.69.Trading volume  remained 247,637 below its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IE00B19Z3581.USD","LU0345769631.USD","TMED","JDOC","LU1221951129.SGD","SGXZ80539844.SGD","LU0994945656.USD","LU1721429741.USD","LU0289739699.SGD","SG9999002232.USD","LU2112291526.USD","IXJ","LU1721429402.USD","LU1718418525.SGD","IHI","LU1551013425.SGD","IE000WAW04H5.SGD","LU0289739343.SGD","LU2552382132.HKD","XLP","XLV","IE00B3PB1722.GBP","MEDX","GDOC","IE000F7OJYX1.SGD","PJP","FSTA","IYH","TRUH","LU0069063385.USD","PG","LU1043141396.HKD","FHLC","IHE","IE00BLSP4452.SGD","UGE","SG9999015341.SGD","LU1506573853.SGD","FTXH","PRGO","TRUO","ABT","LU0289961442.SGD","BK4534","JNJ","LU1162221912.USD","RXL","VHT","SGXZ23171101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672629967","title":"Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2672629967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672629967?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:37","pubTimestamp":1790887025,"startTime":"0","endTime":"0","summary":"The latest update is out from Nanobiotix ( ($FR:NANO) ). Nanobiotix is a late‑stage French biotechnology company developing physics‑based therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","FHLC","JDOC","SYNB","IEIH","XBIX","AGNG","FWD","BBP","IBB","BK4588","NANO","NVIB","RSPH","DARP","BK4585","XT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":2,"totalSize":321,"code":"91000000","status":"200"}]}}